GT200200150A - Cadenas quimericas codificantes para proteinas inductoras de efectos contra virus - Google Patents
Cadenas quimericas codificantes para proteinas inductoras de efectos contra virusInfo
- Publication number
- GT200200150A GT200200150A GT200200150A GT200200150A GT200200150A GT 200200150 A GT200200150 A GT 200200150A GT 200200150 A GT200200150 A GT 200200150A GT 200200150 A GT200200150 A GT 200200150A GT 200200150 A GT200200150 A GT 200200150A
- Authority
- GT
- Guatemala
- Prior art keywords
- chemical
- chains
- virus effects
- coding chains
- inductive proteins
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000003321 amplification Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000008348 humoral response Effects 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE CON LA OBTENCION DE CADENAS NUCLEOTIDICAS QUIMERICAS, LAS CUALES AL SER INTRODUCIDAS EN UN VECTOR DE EXPRESION, DAN COMO RESULTADO PROTEINAS CAPACES DE INDUCIR RESPUESTA HUMORAL SEROTIPO ESPECIFICA Y PROTECCION FRENTE A LA INFECCION POR EL VIRUS DEL DENGUE, EVITANDOSE LOS EFECTOS DE AMPLIFICACION VIRAL SEROTIPO INESPECIFICOS CAUSANTES DE LAS HEMORRAGIAS Y COMPLICACIONES CLINICAS DESCRITAS EN ESTE TIPO DE PATOLOGIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20010172A CU23245A1 (es) | 2001-07-16 | 2001-07-16 | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200150A true GT200200150A (es) | 2003-06-19 |
Family
ID=40091633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200150A GT200200150A (es) | 2001-07-16 | 2002-07-12 | Cadenas quimericas codificantes para proteinas inductoras de efectos contra virus |
Country Status (18)
Country | Link |
---|---|
US (4) | US7279164B2 (es) |
EP (1) | EP1418180B1 (es) |
JP (1) | JP4417712B2 (es) |
KR (1) | KR100991717B1 (es) |
CN (1) | CN100378123C (es) |
AT (1) | ATE349466T1 (es) |
BR (1) | BR0211178A (es) |
CA (1) | CA2453300C (es) |
CU (1) | CU23245A1 (es) |
DE (1) | DE60217129T2 (es) |
DK (1) | DK1418180T3 (es) |
ES (1) | ES2278041T3 (es) |
GT (1) | GT200200150A (es) |
MX (1) | MXPA04000486A (es) |
MY (1) | MY138482A (es) |
PT (1) | PT1418180E (es) |
WO (1) | WO2003008571A2 (es) |
ZA (1) | ZA200400289B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23245A1 (es) * | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
CU23578A1 (es) * | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
CU23586A1 (es) | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus |
CU23630A1 (es) * | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
CU20080028A6 (es) * | 2008-02-29 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus |
JP6018575B2 (ja) | 2010-10-29 | 2016-11-02 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | デングウイルス組換えサブユニットスワクチン |
CU24188B1 (es) * | 2012-12-27 | 2016-07-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal contra el virus dengue |
ITRM20130458A1 (it) * | 2013-08-05 | 2015-02-05 | Internat Ct For Genetic En Gineering And | Vaccino genetico anti-dengue virus basato sugli ectodomini della proteina envelope |
CN113651885B (zh) * | 2018-04-04 | 2022-04-15 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU22302A1 (es) | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
ES2254055T3 (es) | 1991-09-19 | 2006-06-16 | The United States Of America, As Represented By The Secretary, Departm. Of Health And Human Services | Flavivirus quimericos y/o de crecimiento restringido. |
WO1996037221A1 (en) | 1995-05-24 | 1996-11-28 | Hawaii Biotechnology Group, Inc. | Subunit vaccine against flavivirus infection |
CU22559A1 (es) * | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
EP0907659A1 (en) | 1996-05-10 | 1999-04-14 | Schering Corporation | Synthetic inhibitors of hepatitis c virus ns3 protease |
CU22666A1 (es) | 1996-11-25 | 2001-04-27 | Inst De Medicina Tropical Pedro Kouri | Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados |
CU22683A1 (es) * | 1997-01-15 | 2001-07-20 | Inst De Medicina Tropical Pedro Kouri | Epítopes de la proteína pre-m/m del virus del dengue, péptidos sintéticos, proteínas quiméricas y sus usos |
ES2241157T3 (es) | 1997-08-11 | 2005-10-16 | Boehringer Ingelheim (Canada) Ltd. | Peptidos inhibidores de la hepatitis c. |
AU9794198A (en) | 1997-10-08 | 1999-04-27 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Chimeric vaccine against tick-borne encephalitis virus |
DK1185691T3 (da) | 1999-04-30 | 2009-06-22 | Novartis Vaccines & Diagnostic | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf |
CU23245A1 (es) * | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
WO2003101397A2 (en) * | 2002-05-31 | 2003-12-11 | Acambis, Inc. | Tetravalent dengue vaccines |
AU2003300831A1 (en) | 2002-12-11 | 2004-06-30 | Hawaii Biotech, Inc. | Recombinant vaccine against flavivirus infection |
EP1454988A1 (en) | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
WO2005002501A2 (en) | 2003-04-22 | 2005-01-13 | Children's Medical Center Corporation | Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
EP1841785A2 (en) | 2005-01-19 | 2007-10-10 | Vaxinnate Corporation | Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
CA2508266A1 (fr) | 2005-06-20 | 2006-12-20 | Institut Pasteur | Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae |
CU23632A1 (es) | 2006-04-28 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Métodos para la identificación de candidatos terapéuticos contra enfermedades causadas por flavivirus y moléculas antivirales. |
-
2001
- 2001-07-16 CU CU20010172A patent/CU23245A1/es unknown
-
2002
- 2002-07-10 MY MYPI20022623A patent/MY138482A/en unknown
- 2002-07-12 GT GT200200150A patent/GT200200150A/es unknown
- 2002-07-12 KR KR1020047000610A patent/KR100991717B1/ko not_active IP Right Cessation
- 2002-07-12 US US10/484,114 patent/US7279164B2/en not_active Expired - Fee Related
- 2002-07-12 BR BR0211178-0A patent/BR0211178A/pt not_active IP Right Cessation
- 2002-07-12 AT AT02760073T patent/ATE349466T1/de not_active IP Right Cessation
- 2002-07-12 JP JP2003514888A patent/JP4417712B2/ja not_active Expired - Fee Related
- 2002-07-12 EP EP02760073A patent/EP1418180B1/en not_active Expired - Lifetime
- 2002-07-12 CN CNB028143507A patent/CN100378123C/zh not_active Expired - Fee Related
- 2002-07-12 MX MXPA04000486A patent/MXPA04000486A/es active IP Right Grant
- 2002-07-12 DE DE60217129T patent/DE60217129T2/de not_active Expired - Lifetime
- 2002-07-12 DK DK02760073T patent/DK1418180T3/da active
- 2002-07-12 WO PCT/CU2002/000006 patent/WO2003008571A2/es active IP Right Grant
- 2002-07-12 CA CA2453300A patent/CA2453300C/en not_active Expired - Fee Related
- 2002-07-12 PT PT02760073T patent/PT1418180E/pt unknown
- 2002-07-12 ES ES02760073T patent/ES2278041T3/es not_active Expired - Lifetime
-
2004
- 2004-01-14 ZA ZA200400289A patent/ZA200400289B/xx unknown
-
2007
- 2007-02-13 US US11/705,696 patent/US7566457B2/en not_active Expired - Fee Related
-
2009
- 2009-06-12 US US12/483,607 patent/US7947281B2/en not_active Expired - Fee Related
-
2011
- 2011-04-26 US US13/094,287 patent/US8105606B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4417712B2 (ja) | 2010-02-17 |
US8105606B2 (en) | 2012-01-31 |
WO2003008571A2 (es) | 2003-01-30 |
EP1418180B1 (en) | 2006-12-27 |
CA2453300A1 (en) | 2003-01-30 |
CN100378123C (zh) | 2008-04-02 |
CU23245A1 (es) | 2007-10-17 |
ZA200400289B (en) | 2004-09-12 |
KR20040030056A (ko) | 2004-04-08 |
WO2003008571A3 (es) | 2004-03-04 |
DE60217129D1 (de) | 2007-02-08 |
US20070141081A1 (en) | 2007-06-21 |
US7279164B2 (en) | 2007-10-09 |
ES2278041T3 (es) | 2007-08-01 |
BR0211178A (pt) | 2004-08-10 |
US7566457B2 (en) | 2009-07-28 |
US7947281B2 (en) | 2011-05-24 |
MY138482A (en) | 2009-06-30 |
MXPA04000486A (es) | 2005-03-07 |
CA2453300C (en) | 2012-03-20 |
DK1418180T3 (da) | 2007-05-07 |
US20090274718A1 (en) | 2009-11-05 |
ATE349466T1 (de) | 2007-01-15 |
WO2003008571A9 (es) | 2004-04-15 |
KR100991717B1 (ko) | 2010-11-03 |
DE60217129T2 (de) | 2007-10-31 |
CN1531548A (zh) | 2004-09-22 |
US20040234951A1 (en) | 2004-11-25 |
JP2004537306A (ja) | 2004-12-16 |
PT1418180E (pt) | 2007-04-30 |
EP1418180A2 (en) | 2004-05-12 |
US20110200628A1 (en) | 2011-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200200150A (es) | Cadenas quimericas codificantes para proteinas inductoras de efectos contra virus | |
ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
CO6210761A2 (es) | Vectores de virus oncoliticos de viruela | |
AR044724A1 (es) | Promotores del virus de la rizadura amarilla del cestrum | |
ES2061996T3 (es) | Regiones no esenciales de avipoxvirus. | |
ES2174097T3 (es) | Secuencias novedosas del termino 3' del genoma del virus de la hepatitis c y usos terapeuticos y diagnosticos de la misma. | |
DK1412493T3 (da) | Fremgangsmåder og sammensætninger der angår forbedrede lentiviral-vektor.-produktionsystemer | |
ATE330007T1 (de) | Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen | |
ES2145000T3 (es) | Virus recombinante del avipox. | |
PE20210341A1 (es) | Composiciones de virus adeno-asociadas para la transferencia de genes pah y metodos de uso de los mismos | |
KR100469936B1 (ko) | 사스 바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물 | |
PE20121171A1 (es) | Metodo, kit, plasmido y composicion para inducir una respuesta inmunitaria contra el virus del dengue basandose en vacunas de adn y virus quimericos | |
ATE365807T1 (de) | Hepatitis b virus vektoren für gentherapie | |
DK1536015T3 (da) | Promotorer til ekspression i modificeret vacciniavirus Ankara | |
CO6241171A2 (es) | Poxvirus de mapache que expresa genes de virus porcino | |
EA200401505A1 (ru) | Экспрессия генов модифицированного вируса осповакцины ankara с использованием ati-промотора вируса коровьей оспы | |
AR121910A1 (es) | UNA VACUNA CONTRA EL SARS-CoV-2 Y PREPARACIÓN DE LA MISMA | |
ES2118242T3 (es) | Vacunas anti virus de la inmunodeficiencia felina (fiv). | |
AR028977A1 (es) | Genes de lipoxigenasa, promotores, peptidos de transito y proteinas de los mismos | |
DE60040219D1 (de) | Infektiöses cdna klon des gb-virus b und dessen verwendungen | |
AR124461A1 (es) | VACUNA BASADA EN AAV5 PARA LA INDUCCIÓN DE INMUNIDAD ESPECÍFICA CONTRA EL SARS-CoV-2 Y/O LA PREVENCIÓN DE LA INFECCIÓN POR CORONAVIRUS RELACIONADA CON EL SARS-CoV-2 | |
ATE338826T1 (de) | Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression | |
AR115379A1 (es) | Ácido nucleico para tratar alergia a los ácaros | |
PE20130341A1 (es) | Vacuna de adn contra el virus de la fiebre amarilla | |
CO2020013963A2 (es) | Ácido nucleico para tratar la alergia a los mariscos |